Deuterium Capital Management, LLC - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 24 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Deuterium Capital Management, LLC ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,800
-64.9%
11,000
-50.0%
0.02%
+23.5%
Q2 2023$25,080
+52.0%
22,000
+100.0%
0.02%
-34.6%
Q1 2023$16,500
-6.9%
11,000
-7.6%
0.03%
-44.7%
Q4 2022$17,73111,9000.05%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Duquesne Family Office 100,000$231,0000.01%
FNY Investment Advisers, LLC 3,500$8,0000.01%
LEO BROKERAGE, LLC 14,845$34,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 37,900$88,0000.00%
UBS Group AG 13,618$31,0000.00%
RHUMBLINE ADVISERS 16,169$37,0000.00%
Ellevest, Inc. 19$00.00%
TWO SIGMA INVESTMENTS, LP 62,184$144,0000.00%
FMR LLC 179$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 10,375$24,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders